Tuberculosis is treated with a combination of antibiotics taken for several months. Most people with drug-susceptible TB take medications for four to nine months, depending on the regimen. Treatment uses multiple drugs at once because the bacteria that cause TB are unusually hardy, and a single antibiotic isn’t enough to kill them all. The good news: when treatment is followed correctly, TB is curable.
How your treatment looks depends on whether you have latent TB (infected but not sick) or active TB disease, and whether the bacteria respond to standard drugs.
Latent TB vs. Active TB Disease
If you test positive for TB but have no symptoms and can’t spread it to others, you have latent TB infection. About 5 to 10 percent of people with untreated latent TB will eventually develop active disease, so treatment now prevents that from happening. Latent TB treatment is shorter and simpler, typically involving one or two medications for three to four months.
Active TB disease means the bacteria are multiplying, causing symptoms like a persistent cough, weight loss, night sweats, and fever. Active pulmonary TB is contagious. Treatment is longer, uses more drugs, and is split into two phases.
Treating Latent TB Infection
The CDC recommends short-course regimens of three or four months over the older approach of taking a single drug for six to nine months. The preferred options are:
- 3 months of once-weekly two-drug therapy (3HP): Two medications taken together once a week for 12 total doses. This is recommended for most people aged two and older, including many people with HIV.
- 4 months of daily single-drug therapy (4R): One medication taken daily for 120 doses. This works well for people who can’t tolerate the other drugs or were exposed to a resistant strain.
- 3 months of daily two-drug therapy (3HR): Two medications taken daily for 90 doses. An option for both children and adults.
These shorter regimens are easier to complete, which matters because the biggest challenge with latent TB treatment is sticking with it long enough.
Standard Treatment for Active TB
Active TB treatment happens in two phases. The intensive phase hits the bacteria hard with four drugs at once for two months. The continuation phase drops to fewer drugs and lasts another two to seven months, depending on the regimen.
The 6- to 9-Month Regimen
The traditional approach uses four antibiotics during the intensive phase for eight weeks, then two antibiotics during the continuation phase for four to seven more months. Medications are taken daily or several times per week. This has been the global standard for decades and remains widely used.
The Newer 4-Month Regimen
A shorter regimen is now available for certain patients. It uses a slightly different combination of drugs, taken daily with food for about 17 weeks total: eight weeks in the intensive phase, then nine weeks in the continuation phase, for 119 total doses. You’re eligible if you’re at least 12 years old, weigh at least 40 kg (about 88 pounds), and have TB that isn’t drug-resistant. People with HIV can qualify if their immune cell counts are above a certain threshold and their HIV medications are compatible.
This shorter regimen is a meaningful advance. Cutting treatment from six months to four months reduces the burden on patients and may help more people finish their full course.
How Doctors Know Treatment Is Working
The clearest sign that TB treatment is working is sputum culture conversion. This means that samples you cough up, which initially grew TB bacteria in the lab, stop growing them. Successful conversion is defined as at least two consecutive negative cultures. When this happens within the first 60 days of treatment, it helps your care team decide how to structure the rest of your regimen. You’ll also notice symptoms improving: less coughing, returning appetite, weight stabilizing, and fevers resolving.
Side Effects to Watch For
TB drugs are effective but can be tough on the body. The most common side effects are stomach upset, nausea, loss of appetite, rash, and fever. The more serious concern is liver damage, since several of the core TB medications are processed through the liver. Warning signs include yellowing of the skin or eyes, dark brown urine, light-colored stool, persistent fatigue, and abdominal pain. If you notice these, contact your care team right away rather than waiting for your next appointment.
One of the TB drugs can affect vision, causing blurred sight or changes in color perception. You may be asked to have your eyes checked before and during treatment. Another commonly causes joint aches by raising uric acid levels in the blood, which can feel like gout.
One important supplement: vitamin B6 (pyridoxine) at 25 to 50 mg daily is given alongside one of the core TB drugs to prevent nerve damage. Without it, you might develop tingling, numbness, or pain in your hands and feet. This is a simple preventive step that your care team should build into your treatment plan from day one.
Why Finishing Every Dose Matters
TB treatment requires an unusually long commitment compared to most infections. You’ll likely start feeling better within a few weeks, but the bacteria aren’t gone yet. Stopping early or skipping doses is the main driver of drug-resistant TB, which is far harder and longer to treat.
To help with this, the standard approach is directly observed therapy (DOT), where a healthcare worker watches you take each dose. This isn’t a sign of distrust. The CDC recommends DOT for all TB patients because there’s no reliable way to predict who will have trouble sticking with a months-long regimen. DOT can happen in person or remotely through video calls on a phone, tablet, or computer (called eDOT). During each encounter, the healthcare worker also checks in about side effects, which means problems get caught early.
Drug-Resistant TB Treatment
When TB bacteria don’t respond to the standard first-line drugs, treatment becomes more complex. Multidrug-resistant TB (MDR-TB) resists at least the two most powerful standard antibiotics. For patients 14 and older with MDR-TB, a six-month all-oral regimen called BPaLM is now available, using a combination of newer antibiotics. If there’s additional resistance to a key drug class, a three-drug version (BPaL) can be used instead.
These newer regimens are a significant improvement over older MDR-TB treatments, which could last 18 months or longer and often involved injectable drugs with harsh side effects. After completing a BPaLM or BPaL regimen, you’ll be monitored for two years to confirm the infection doesn’t return. Patients who aren’t eligible for these regimens, including pregnant women, children under 14, and those with resistance to the newer drugs, receive an individualized treatment plan.
TB Treatment With HIV
Having both TB and HIV complicates treatment because the diseases worsen each other and the medications can interact. The key principle is that anyone with both conditions needs treatment for both, and TB treatment typically starts first. How quickly HIV treatment begins depends on how suppressed the immune system is. People with very low immune cell counts (below 50 cells per cubic millimeter) should start HIV medications within two weeks of beginning TB treatment. Those with higher counts have a wider window of two to eight weeks.
Drug interactions between TB and HIV medications are a real challenge. Some combinations can reduce the effectiveness of one or both treatments, so your care team will carefully select compatible drugs. The newer four-month TB regimen and certain latent TB regimens have restrictions for people with HIV depending on which antiretroviral medications they take.